Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00RQU
|
||||
| Former ID |
DIB002320
|
||||
| Drug Name |
Low molecular weight heparin
|
||||
| Synonyms |
Low molecular weight heparin (solid oral, eligen); LMWH/SNAD (solid oral), Emisphere; Low molecular weight heparin (solid oral, eligen), Emisphere
|
||||
| Indication | Thrombosis [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Phase 3 | [549903] | ||
| Company |
Emisphere Technologies Inc
|
||||
| Formula |
C26H42N2O37S5
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Antithrombin-III | Target Info | Modulator | [544009] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Blood coagulation | ||||
| Pathway Interaction Database | Glypican 1 network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.